The company has reported the first phase 3 results in hand for gadoquatrane, which reduces the dose of gadolinium delivered ...

Bayer presents positive results from phase III study QUANTI CNS of gadoquatrane at ECR 2025: Berlin Thursday, February 27, 2025, 14:00 Hrs [IST] Bayer, a global leader in radiolog ...

Sanochemia Pharmazeutika today announced positive headline results of the pivotal phase III study PROSTAPROGRESS on Ferumoxtran (EudraCT 2018-004310-18), performed by SPL Medical B.V. (Nijmegen, The ...

Bayer, a global leader in radiology, announced positive results from the Phase III study QUANTI CNS, which evaluated the ...

In a nutshell Human brain neurons maintain consistent responses to people and objects regardless of context—unlike animal ...

Dust and rocks residing on the surface of the moon take a beating in space. Without a protective magnetosphere and atmosphere ...

Little is known about the associated brain activation during these sleep rhythms, and even less about their functional implications. In this study, we investigated the brain-wide activation underlying ...

From IIT Guwahati, AIIMS to Lilavati Hospital and Apollo Diagnostics, the transition from traditional to 'smart' microscopes ...

A research team led by Professor Kevin Tsia, programme director of the Biomedical Engineering Programme under the Faculty of Engineering of the University of Hong Kong (HKU), has developed an ...

A research team led by Professor Kevin Tsia, programme director of the Biomedical Engineering Programme under the Faculty of Engineering of the University of Hong Kong (HKU), has developed an ...

A research team led by Professor Kevin Tsia, program director of the Biomedical Engineering Program under the Faculty of Engineering of the University of Hong Kong (HKU), has developed an AI-driven ...

On Wednesday, Recursion announced favorable efficacy data in the Phase II trial for REC-994 ... who is now senior director of the Imaging Platform at the Broad Institute, Gibson used AI-based ...